A method of treating Restless Leg Syndrome, includes administering to a subject an iron complex having an iron release rate greater than IDI. The iron release rate is determined at a concentration of at least 2,000 g/dl.

 
Web www.patentalert.com

< Echinocandin pharmaceutical formulations containing micelle-forming surfactants

< Hepatitis C virus non-structural NS3/4A fusion gene

> Anti-idiotype antibodies to MN proteins and MN polypeptides

> Composition comprising camptothecin or a comptothecin derivative and a platin derivative for the treatment of cancer
~ 00217